Leelavathi D Acharya
Overview
Explore the profile of Leelavathi D Acharya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
The impact of the offline metabolic monitoring tool on psychiatric care: Findings from a cluster RCT
Poojari P, Shenoy S, Khan S, Pai K, Shetty S, Bhat S, et al.
Asian J Psychiatr
. 2025 Feb;
105:104406.
PMID: 40010111
No abstract available.
2.
Poojari P, Mey A, Khan S, Shenoy S, Pai K, Shetty S, et al.
J Health Psychol
. 2025 Feb;
:13591053251315263.
PMID: 39953865
Second-generation antipsychotics are highly effective in controlling symptoms if taken as prescribed. However, poor medication adherence results in patients continuing to experience psychotic episodes and metabolic disturbances that can cause...
3.
Prathiksha A, Shantaram P, Rashid M, Poojari P, Nair S, Acharya L, et al.
Diabetes Metab Syndr
. 2024 Nov;
18(10):103139.
PMID: 39490236
Aim: We performed a scoping review to identify the diabetes care determinants and barriers in patients with serious mental illness (SMI), in view of limited evidence and clarity. Methods: We...
4.
Reghunath S, Chackochan A, Thunga G, Acharya D, Shivashankara K, Prabhu A, et al.
Clin Med Insights Endocrinol Diabetes
. 2024 Nov;
17:11795514241288645.
PMID: 39483777
Background: Dipeptidyl peptidase-4 (DPP-4) inhibitors are oral hypoglycemic agents widely prescribed in India despite safety concerns. However, studies focused on their safety profile are scarce, especially in South India. Objective:...
5.
Nayak S, Amin A, Reghunath S, Thunga G, Acharya U D, Shivashankara K, et al.
Int J Med Inform
. 2024 Jul;
190:105546.
PMID: 39003788
Background: Diabetic kidney disease (DKD) is a diabetic microvascular complication often characterized by an unpredictable progression. Hence, early detection and recognition of patients vulnerable to progression is crucial. Objective: To...
6.
Reghunath S, Rashid M, Chandran V, Thunga G, Shivashankar K, Acharya L
Diabetes Metab Syndr
. 2023 Jun;
17(7):102790.
PMID: 37329838
Background And Aim: Adverse drug reactions are one of the contributors to increased hospital admission and length of hospital stay. Among the various antidiabetic agents prescribed, dipeptidyl peptidase-4 (DPP-4) inhibitors...
7.
Poojari P, Khan S, Shenoy S, Shetty S, Pai K, Acharya L, et al.
PLoS One
. 2023 Apr;
18(4):e0283317.
PMID: 37075039
Objectives: We conducted a meta-synthesis of qualitative studies to synthesize the views of psychiatric patients on second-generation antipsychotics (SGAs) and the healthcare providers about the metabolic monitoring of adult-prescribed SGAs....
8.
Shetty R, Basheer F, Poojari P, Thunga G, Chandran V, Acharya L
Diabetes Metab Syndr
. 2022 Feb;
16(3):102427.
PMID: 35217468
Background And Aim: The importance of glucagon-like peptide-1 (GLP-1) agonists is increasing because of its blood sugar controlling and weight loss properties. The data regarding safety of GLP-1 agonists are...
9.
Sabu S, Seshadri S, Thunga G, Poojari P, Acharya L
J Pharm Bioallied Sci
. 2020 Aug;
12(1):48-56.
PMID: 32801600
Objective: The objective of this study was to determine the association between antihypertensive drug use and new-onset diabetes (NOD) in patients with hypertension (HTN). Materials And Methods: A retrospective observational...
10.
Poojari P, Khan S, Shenoy S, Acharya L, Shetty S, Bose S, et al.
Asian J Psychiatr
. 2020 Jun;
53:102186.
PMID: 32563106
The objectives of this study were to identify the risk factors for metabolic syndrome in patients on antipsychotics and to compare the frequency of metabolic monitoring with evidence-based guidelines. We...